Research Theme
Cardiology
Research Group
Department/Faculty Affiliations
Department of Physiology, Anatomy, and Genetics; MRC/BHF Centre of Research Excellence in Advanced Cardiac Therapies
Current Area of Research
RNA therapeutic technology; mRNA translation; Drug Discovery Technology
Dr Thomas Mulroney studied Biochemistry at the University of Birmingham, UK. In 2016 he started his PhD supervised by Prof Anne Willis investigating nucleotide modifications in synthetic mRNAs and oligonucleotide drugs. During his PhD he worked at the Medical Research Council Toxicology Unit, the University of Cambridge Biochemistry Department, and AstraZeneca, funded by the Medical Research Council Integrative Toxicology Training Partnership. He received his PhD from Jesus College Cambridge in 2021.
Since his PhD, Dr Mulroney worked as a postdoctoral research scientist at the MRC Toxicology Unit investigating RNA therapeutics, funded by Wellcome Leap RNA Readiness and Response. He then joined the University of Oxford Engineered Biotechnology Research Group (Prof Harrison Steel), to investigate new technology for drug discovery and biosensing. Dr Mulroney has recently joined the IDRM/DPAG to investigate new approaches to develop RNA therapeutics for cardiovascular disease, funded by the British Heart Foundation.